Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
153.6 EUR | +4.03% | +1.69% | +6.63% |
Apr. 23 | US competitor Danaher boosts Merck KGaA and Sartorius | DP |
Apr. 19 | MERCK KGAA : Barclays reiterates its Buy rating | ZD |
Sales 2024 * | 21.25B 22.74B | Sales 2025 * | 22.5B 24.08B | Capitalization | 66.8B 71.5B |
---|---|---|---|---|---|
Net income 2024 * | 2.97B 3.18B | Net income 2025 * | 3.48B 3.72B | EV / Sales 2024 * | 3.46 x |
Net Debt 2024 * | 6.79B 7.27B | Net Debt 2025 * | 4.83B 5.17B | EV / Sales 2025 * | 3.18 x |
P/E ratio 2024 * |
22.5
x | P/E ratio 2025 * |
19.1
x | Employees | 62,908 |
Yield 2024 * |
1.5% | Yield 2025 * |
1.57% | Free-Float | 29.71% |
Latest transcript on Merck KGaA
1 day | +4.03% | ||
1 week | +0.95% | ||
Current month | -6.08% | ||
1 month | -5.04% | ||
3 months | +3.85% | ||
6 months | +3.26% | ||
Current year | +6.63% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 20-07-12 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 14-07-31 |
Director of Finance/CFO | 53 | 19-04-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 75 | 14-05-08 | |
Christian Raabe
BRD | Director/Board Member | - | - |
Chairman | 67 | 19-04-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.34% | 2 M€ | +13.56% | - | |
2.01% | 0 M€ | 0.00% | - | |
1.80% | 962 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 153.6 | +4.03% | 503,255 |
24-04-22 | 147.7 | +1.16% | 214,993 |
24-04-19 | 146 | -0.51% | 353,173 |
24-04-18 | 146.8 | -0.31% | 511,371 |
24-04-17 | 147.2 | -2.58% | 370,848 |
Delayed Quote Xetra, April 23, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.63% | 68.35B | |
+12.05% | 9.18B | |
-16.33% | 4.78B | |
+6.40% | 3.87B | |
+26.98% | 3.73B | |
+28.27% | 2.52B | |
-26.55% | 2.27B | |
-25.02% | 2.21B | |
+5.82% | 1.95B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- MRK Stock